Care Pro Bioscience Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.13 Cr
as on 19-12-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 3.26 Cr
as on 19-12-2024
- Revenue -84.73%
(FY 2022)
- Profit 11.88%
(FY 2022)
- Ebitda 24.11%
(FY 2022)
- Net Worth -7.32%
(FY 2022)
- Total Assets 0.82%
(FY 2022)
About Care Pro Bioscience
The Corporate was formerly known as Cpb India Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.13 Cr.
The company has closed loans amounting to ₹3.26 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kshyama Singh and Sitaram Paikray serve as directors at the Company.
- CIN/LLPIN
U85110UP2005PTC069538
- Company No.
069538
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2005
- Date of AGM
05 Jun 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationGreater Noida, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Care Pro Bioscience Private Limited offer?
Care Pro Bioscience Private Limited offers a wide range of products and services, including Plant Growth Regulators, Nagarjuna Plant Growth Regulators, Insecticides, Biopesticides, Nitrogen Fertilizers, NPK Fertilizer, FMC Plant Growth Regulators, Fertilizer, Bio Fertilizers, Soil Probiotics and inoculants.
Who are the key members and board of directors at Care Pro Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kshyama Singh  | Director | 01-Jun-2005 | Current |
| Sitaram Paikray | Director | 01-Jun-2005 | Current |
Financial Performance of Care Pro Bioscience.
Care Pro Bioscience Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.73% decrease. The company also saw a substantial improvement in profitability, with a 11.88% increase in profit. The company's net worth dipped by a decrease of 7.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Care Pro Bioscience?
In 2022, Care Pro Bioscience had a promoter holding of 84.37% and a public holding of 15.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Care - Pro Bio Technologies Private LimitedActive 17 years 5 months
Kshyama Singh and Sitaram Paikray are mutual person
- International Traceability Systems LimitedActive 18 years 8 months
Kshyama Singh and Sitaram Paikray are mutual person
- Immuno Vitalis Global Private LimitedActive 10 months 1 day
Kshyama Singh and Sitaram Paikray are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jun 2019 | ₹3.23 Cr | Satisfied |
Mitter Finance Company Limited Creation Date: 25 Jan 2010 | ₹0.32 M | Satisfied |
How Many Employees Work at Care Pro Bioscience?
Care Pro Bioscience has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Care Pro Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Care Pro Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
